Eli Lilly and Company
The Advisor, LNP Characterization — Analytical Development role supports the formulation, process development, and product release for next-generation RNA-LNP-based therapies. This position focuses on characterizing lipid nanoparticle formulations using biophysical techniques to drive deep product and process understanding. The role involves collaborating with cross-functional teams to ensure product quality and safety throughout the development lifecycle.
Headquarters
Indianapolis, Indiana, United States
Company Size
10001+ employees
Founded
1876
Eli Lilly and Company is a global biopharmaceutical company headquartered in Indianapolis, Indiana. It discovers, develops, manufactures and commercializes prescription medicines across therapeutic areas including diabetes, oncology, immunology, neuroscience and pain, and has a longstanding history in insulin and other major drug discoveries. Lilly invests heavily in research and clinical development and partners with biotech, academic institutions, and industry collaborators to advance biologics, small molecules, and precision medicines. The company operates global manufacturing and commercial networks and provides patient-support programs to improve access to its therapies.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Eli Lilly and Company.
49% above the average for this role
Li Auto OTA Upgrade And Charging Use Test Investor Patience
1 week ago
Senior Scientist I/II, Analytical Development
AbbVie
Senior Scientist II, Analytical Development
AbbVie
Senior Scientist II - Principal Scientist I, Analytical R&D (Particle Characterization)
AbbVie
Scientist II, LNP
CRISPR Therapeutics
Contract SRA / Scientist, Lipid Nanoparticle (LNP) Discovery
Addition Therapeutics
Scientist
Moderna